26.74
price up icon0.11%   0.03
after-market Handel nachbörslich: 26.59 -0.15 -0.56%
loading
Schlusskurs vom Vortag:
$26.71
Offen:
$26.92
24-Stunden-Volumen:
353.41K
Relative Volume:
2.10
Marktkapitalisierung:
$1.69B
Einnahmen:
$286.00M
Nettoeinkommen (Verlust:
$305.47M
KGV:
-11.41
EPS:
-2.3434
Netto-Cashflow:
$-492.33M
1W Leistung:
-6.31%
1M Leistung:
-8.39%
6M Leistung:
-8.08%
1J Leistung:
-27.85%
1-Tages-Spanne:
Value
$26.71
$27.20
1-Wochen-Bereich:
Value
$26.35
$28.91
52-Wochen-Spanne:
Value
$24.16
$42.45

Galapagos Nv Adr Stock (GLPG) Company Profile

Name
Firmenname
Galapagos Nv Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
GLPG's Discussions on Twitter

Galapagos Nv Adr Stock (GLPG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-09 Eingeleitet Leerink Partners Market Perform
2024-08-02 Herabstufung Raymond James Outperform → Mkt Perform
2024-03-28 Herabstufung BofA Securities Neutral → Underperform
2024-03-07 Fortgesetzt Morgan Stanley Equal-Weight
2023-08-24 Herabstufung Citigroup Buy → Neutral
2023-05-05 Hochstufung Raymond James Mkt Perform → Outperform
2023-01-23 Hochstufung Jefferies Underperform → Hold
2022-11-07 Herabstufung Raymond James Outperform → Mkt Perform
2022-09-09 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-01-27 Hochstufung Citigroup Neutral → Buy
2021-08-19 Herabstufung Barclays Overweight → Equal Weight
2021-08-06 Herabstufung Deutsche Bank Buy → Hold
2021-04-20 Eingeleitet Deutsche Bank Buy
2021-04-14 Hochstufung Barclays Equal Weight → Overweight
2021-02-23 Hochstufung BofA Securities Underperform → Neutral
2021-02-19 Hochstufung Raymond James Mkt Perform → Outperform
2021-02-11 Herabstufung Citigroup Buy → Neutral
2021-01-19 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-11-19 Eingeleitet Maxim Group Buy
2020-10-21 Herabstufung Goldman Neutral → Sell
2020-08-25 Herabstufung Jefferies Buy → Hold
2020-08-24 Herabstufung H.C. Wainwright Buy → Neutral
2020-08-19 Herabstufung Barclays Overweight → Equal Weight
2020-08-19 Hochstufung Citigroup Neutral → Buy
2020-07-10 Herabstufung Stifel Buy → Hold
2020-03-30 Hochstufung Jefferies Hold → Buy
2020-03-18 Hochstufung RBC Capital Mkts Underperform → Sector Perform
2020-02-25 Herabstufung Cantor Fitzgerald Overweight → Neutral
2020-02-24 Herabstufung BofA/Merrill Neutral → Underperform
2020-02-20 Herabstufung RBC Capital Mkts Sector Perform → Underperform
2020-01-06 Herabstufung JP Morgan Overweight → Neutral
2019-12-18 Herabstufung Citigroup Buy → Neutral
2019-12-17 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-12-13 Herabstufung Credit Suisse Outperform → Neutral
2019-12-02 Eingeleitet BofA/Merrill Neutral
2019-09-09 Fortgesetzt Morgan Stanley Overweight
2019-07-31 Hochstufung UBS Neutral → Buy
2019-07-29 Herabstufung Jefferies Buy → Hold
Alle ansehen

Galapagos Nv Adr Aktie (GLPG) Neueste Nachrichten

pulisher
Nov 04, 2024

Deutsche Bank maintains Hold on Galapagos, reducing target with key updates months away - Investing.com

Nov 04, 2024
pulisher
Nov 01, 2024

Earnings call: Galapagos reports solid Q3 progress, eyes IND studies By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Galapagos reports solid Q3 progress, eyes IND studies - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Galapagos stock outlook cautious with clinical readouts on the horizon, says Morgan Stanley - Investing.com

Nov 01, 2024
pulisher
Oct 30, 2024

Galapagos ADR earnings missed by $0.05, revenue topped estimates - Investing.com UK

Oct 30, 2024
pulisher
Sep 16, 2024

Galapagos receives transparency notification from EcoR1 Capital - GlobeNewswire Inc.

Sep 16, 2024
pulisher
Sep 09, 2024

Leerink Partners gives Market Perform rating to Galapagos NV stock, flags R&D challenges - Investing.com

Sep 09, 2024
pulisher
Aug 27, 2024

Navigating GLPG Stock: Galapagos NV ADR Journey - The InvestChronicle

Aug 27, 2024
pulisher
Aug 26, 2024

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 26, 2024
pulisher
Aug 03, 2024

Morgan Stanley cuts Galapagos NV target to $32 from $35 - Investing.com

Aug 03, 2024
pulisher
Aug 02, 2024

Earnings call: Galapagos focuses on oncology and immunology in H1 2024 report - Investing.com

Aug 02, 2024
pulisher
Jul 22, 2024

Belgium stocks higher at close of trade; BEL 20 up 1.37% - Investing.com

Jul 22, 2024
pulisher
Jul 15, 2024

Treasuries slip, dollar firm as markets grapple with US politics By Reuters - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Belgium stocks lower at close of trade; BEL 20 down 0.90% - Investing.com

Jul 15, 2024
pulisher
Jul 09, 2024

Belgium stocks lower at close of trade; BEL 20 down 0.24% By Investing.com - Investing.com

Jul 09, 2024
pulisher
Jul 08, 2024

Belgium stocks lower at close of trade; BEL 20 down 0.32% By Investing.com - Investing.com

Jul 08, 2024
pulisher
Jun 17, 2024

Galapagos NV shares poised for outperformance, says TD Cowen - Investing.com India

Jun 17, 2024
pulisher
Jun 17, 2024

Galapagos NV shares poised for outperformance, says TD Cowen By Investing.com - Investing.com

Jun 17, 2024
pulisher
Jun 14, 2024

Belgium stocks lower at close of trade; BEL 20 down 0.79% By Investing.com - Investing.com

Jun 14, 2024
pulisher
Jun 14, 2024

Belgium shares lower at close of trade; BEL 20 down 0.79% - Investing.com India

Jun 14, 2024
pulisher
Jun 12, 2024

Belgium stocks higher at close of trade; BEL 20 up 1.28% By Investing.com - Investing.com

Jun 12, 2024
pulisher
Jun 12, 2024

Belgium shares higher at close of trade; BEL 20 up 1.28% - Investing.com India

Jun 12, 2024
pulisher
Jun 10, 2024

Belgium stocks lower at close of trade; BEL 20 down 0.40% By Investing.com - Investing.com

Jun 10, 2024
pulisher
Jun 10, 2024

Belgium shares lower at close of trade; BEL 20 down 0.40% - Investing.com India

Jun 10, 2024
pulisher
May 30, 2024

Adaptimmune and Galapagos partner on cancer therapy By Investing.com - Investing.com

May 30, 2024
pulisher
May 30, 2024

Adaptimmune and Galapagos partner on cancer therapy - Investing.com India

May 30, 2024
pulisher
May 10, 2024

Are Medical Stocks Lagging Galapagos (GLPG) This Year? - Yahoo Singapore News

May 10, 2024
pulisher
May 06, 2024

Earnings call: Galapagos outlines strategic focus in Q1 2024 results - Investing.com

May 06, 2024
pulisher
May 03, 2024

Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More - Yahoo News UK

May 03, 2024
pulisher
Apr 17, 2024

Insight venture partners executives sell over $61 million in nCino shares By Investing.com - Investing.com

Apr 17, 2024
pulisher
Mar 28, 2024

Allied Gaming & Entertainment insider buys shares worth over $456,000 By Investing.com - Investing.com

Mar 28, 2024
pulisher
Mar 07, 2024

Morgan Stanley sets Galapagos stock at equalweight, $38 price target By Investing.com - Investing.com

Mar 07, 2024
pulisher
Dec 21, 2023

Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA - Yahoo Finance

Dec 21, 2023
pulisher
May 30, 2022

Morgan Stanley lists biotechs with negative enterprise value, 2022 catalysts (NASDAQ:GLPG) - Seeking Alpha

May 30, 2022
pulisher
Jan 27, 2022

Galapagos Surges On New CEO and Upgrade News - Investing.com

Jan 27, 2022
pulisher
Dec 30, 2020

Galapagos: Market Values Pipeline Below $0 (NASDAQ:GLPG) - Seeking Alpha

Dec 30, 2020
pulisher
Oct 01, 2020

Galapagos Begins Dosing With GLPG3970 in Psoriasis Study - Yahoo Singapore News

Oct 01, 2020
pulisher
Aug 19, 2020

The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs - Benzinga

Aug 19, 2020
pulisher
Aug 16, 2020

The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, IPOs - Yahoo Finance

Aug 16, 2020
pulisher
Jan 17, 2020

The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares - Yahoo Finance

Jan 17, 2020
pulisher
Jan 16, 2020

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves I - Benzinga

Jan 16, 2020
pulisher
Jan 15, 2020

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integr - Benzinga

Jan 15, 2020
pulisher
Dec 13, 2019

Is Galapagos NV (GLPG) A Good Stock To Buy? - Insider Monkey

Dec 13, 2019
pulisher
Dec 10, 2019

The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares - Yahoo Finance

Dec 10, 2019
pulisher
Dec 06, 2019

The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes DividendAlecto - Benzinga

Dec 06, 2019
pulisher
Apr 30, 2019

World’s Top-Selling Drugs: Gilead Sciences, Inc. Sovaldi Closes In On AbbVie Inc Humira - Crypto Coins Tribune

Apr 30, 2019
pulisher
Sep 14, 2018

The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To DebutStaar S - Benzinga

Sep 14, 2018
pulisher
Sep 09, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOsAmarin Corp (NASDAQ:A - Benzinga

Sep 09, 2018
pulisher
Jul 27, 2018

AIM tech shares that broke America - Interactive Investor

Jul 27, 2018
pulisher
Dec 15, 2017

25 Stocks Moving In Friday's Pre-Market SessionAlnylam Pharmaceuticals (NASDAQ:ALNY), Aclaris Therapeu - Benzinga

Dec 15, 2017
pulisher
Aug 14, 2017

Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isn't Worth the Risk - InvestorPlace

Aug 14, 2017

Finanzdaten der Galapagos Nv Adr-Aktie (GLPG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):